Evidence map›Paper›PMID 36478669›Full record

ArticleApplied AI letters2020

Visualizing and understanding inherent features in SD-OCT for the progression of age-related macular degeneration using deconvolutional neural networks.

Sajib Saha, Ziyuan Wang, Srinivas Sadda, Yogesan Kanagasingam, Zhihong Hu

Open access · goldAbstract read
In one paragraph

Article in Applied AI letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Sajib SahaDoheny Eye Institute, Los Angeles, California.ORCID 0000-0002-5839-8985
Ziyuan WangDoheny Eye Institute, Los Angeles, California.
Srinivas SaddaDoheny Eye Institute, Los Angeles, California.
Yogesan KanagasingamAustralian e-Health Research Centre, CSIRO, Perth, Australia.
Zhihong HuDoheny Eye Institute, Los Angeles, California.ORCID 000-0001-8307-0298
Commonwealth Scientific and Industrial Research Organisation · AUUniversity of California, Los Angeles · USDoheny Eye Institute · US

Funding

Discovery and Validation of AMD Biomarkers for Progression Using Deep LearningR21EY030619 · NEI · DOHENY EYE INSTITUTE · PI HU, ZHIHONG, SADDA, SRINIVAS R · 2019 to 2020
$432k
NEI NIH HHS R21 EY030619
6 · The paper itself

Abstract

To develop a convolutional neural network visualization strategy so that optical coherence tomography (OCT) features contributing to the evolution of age-related macular degeneration (AMD) can be better determined. We have trained a U-Net model to utilize baseline OCT to predict the progression of geographic atrophy (GA), a late stage manifestation of AMD. We have augmented the U-Net architecture by attaching deconvolutional neural networks (deconvnets). Deconvnets produce the reconstructed feature maps and provide an indication regarding the inherent baseline OCT features contributing to GA progression. Experiments were conducted on longitudinal spectral domain (SD)-OCT and fundus autofluorescence images collected from 70 eyes with GA. The intensity of Bruch's membrane-outer choroid (BMChoroid) retinal junction exhibited a relative importance of 24%, in the GA progression. The intensity of the inner retinal pigment epithelium (RPE) and BM junction (InRPEBM) showed a relative importance of 22%. BMChoroid (where the AMD feature/damage of choriocapillaris was included) followed by InRPEBM (where the AMD feature/damage of RPE was included) are the layers which appear to be most relevant in predicting the progression of AMD.

Indexed as

age-related macular degenerationAMDCNNconvolutional neural networkdeconvnetdeconvolutional neural networkFAFfundus autofluorescenceSD-OCT

Identifiers

PMID36478669
PMCPMC9725889
OpenAlexW3101783886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.